About Keiretsu Forum Philadelphia

Website
Website
Employees
Employees
1-10 employees View all
Industry
Industry
Venture Capital & Private Equity
Description
Information
Keiretsu Forum is the world’s largest Angel Investor-Private Equity network with more than 850 accredited investor members throughout nineteen chapters on three continents. Since Keiretsu Forum’s founding in 2000, its members have invested over $280m in 250+ companies in technology, consumer products, healthcare/life sciences, real estate and other segments with high growth potential. Forum members collaborate in the due diligence, but make individual investment decisions, with rounds in the range of $250k-$2m. Keiretsu Forum's community is strengthened through education on angel investing, as well as charitable giving. To date, Forum members have donated over $1m to over 100 non-profit organizations.

Keiretsu Forum Philadelphia Alternatives

Industry
venture capital & private equity
Industry
venture capital & private equity
Industry
venture capital & private equity
Industry
Venture Capital & Private Equity
Industry
Venture Capital & Private Equity
Industry
Venture Capital & Private Equity
Industry
venture capital & private equity
Industry
venture capital & private equity
Industry
venture capital & private equity
Industry
venture capital & private equity

Frequently Asked Questions about Keiretsu Forum Philadelphia

What is Keiretsu Forum Philadelphia email format?

The widely used Keiretsu Forum Philadelphia email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Keiretsu Forum Philadelphia customer service number?

To contact Keiretsu Forum Philadelphia customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more